Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Annabel Samimy is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
07/03/2024 | KMDA | Buy Now | Kamada | $5.68 | 216.9% | → $18 | Initiates | → Buy | Get Alert |
05/28/2024 | CALT | Buy Now | Calliditas Therapeutics | $39.08 | 2.35% | $55 → $40 | Downgrade | Buy → Hold | Get Alert |
05/03/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.43 | 130.11% | → $24 | Initiates | → Buy | Get Alert |
04/12/2024 | RGNX | Buy Now | Regenxbio | $10.63 | 276.29% | → $40 | Maintains | Buy | Get Alert |
03/15/2024 | VKTX | Buy Now | Viking Therapeutics | $51.16 | 56.37% | → $80 | Reiterates | Buy → Buy | Get Alert |
03/15/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $100.71 | 128.38% | $225 → $230 | Maintains | Buy | Get Alert |
03/08/2024 | EOLS | Buy Now | Evolus | $11.10 | 125.23% | $23 → $25 | Reiterates | Buy → Buy | Get Alert |
02/16/2024 | IVA | Buy Now | Inventiva | $2.75 | 809.09% | $27 → $25 | Maintains | Buy | Get Alert |
02/14/2024 | VKTX | Buy Now | Viking Therapeutics | $51.16 | -31.59% | $30 → $35 | Maintains | Buy | Get Alert |
11/01/2023 | RGNX | Buy Now | Regenxbio | $10.63 | 229.26% | → $35 | Initiates | → Buy | Get Alert |
10/05/2023 | OCS | Buy Now | Oculis Holding | $12.36 | 183.17% | → $35 | Initiates | → Buy | Get Alert |
08/29/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 75.63% | $60 → $65 | Maintains | Buy | Get Alert |
08/08/2023 | VKTX | Buy Now | Viking Therapeutics | $51.16 | -41.36% | → $30 | Reiterates | → Buy | Get Alert |
07/28/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $110 → $172.5 | Downgrade | Buy → Hold | Get Alert |
06/27/2023 | CARA | Buy Now | Cara Therapeutics | $0.30 | 9295.97% | → $28 | Reiterates | Buy → Buy | Get Alert |
06/26/2023 | FGEN | Buy Now | FibroGen | $0.81 | 1260.54% | $28 → $11 | Downgrade | Buy → Hold | Get Alert |
06/02/2023 | FGEN | Buy Now | FibroGen | $0.81 | — | — | Upgrade | Hold → Buy | Get Alert |
05/16/2023 | VKTX | Buy Now | Viking Therapeutics | $51.16 | -41.36% | $25 → $30 | Maintains | Buy | Get Alert |
04/17/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | $155 → $200 | Downgrade | Buy → Hold | Get Alert |
04/13/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $105 → $115 | Maintains | Buy | Get Alert |
03/28/2023 | VKTX | Buy Now | Viking Therapeutics | $51.16 | -51.13% | $22 → $25 | Maintains | Buy | Get Alert |
03/17/2023 | IVA | Buy Now | Inventiva | $2.75 | 881.82% | → $27 | Initiates | → Buy | Get Alert |
03/17/2023 | VKTX | Buy Now | Viking Therapeutics | $51.16 | -57% | → $22 | Initiates | → Buy | Get Alert |
03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $12.55 | 258.57% | → $45 | Initiates | → Buy | Get Alert |
02/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 102.65% | $65 → $75 | Maintains | Buy | Get Alert |
12/12/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | $138 → $116.5 | Downgrade | Buy → Hold | Get Alert |
11/10/2022 | CLSD | Buy Now | Clearside Biomedical | $1.31 | 510.73% | → $8 | Upgrade | Hold → Buy | Get Alert |
11/01/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $50 → $55 | Maintains | Buy | Get Alert |
10/13/2022 | EVFM | Buy Now | Evofem Biosciences | $0.01 | 7475.76% | $375 → $62.5 | Downgrade | Buy → Hold | Get Alert |
09/08/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 75.63% | $60 → $65 | Maintains | Buy | Get Alert |
09/08/2022 | ISEE | Buy Now | IVERIC bio | — | — | $28 → $35 | Maintains | Buy | Get Alert |
08/23/2022 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | $27 → $15.25 | Downgrade | Buy → Hold | Get Alert |
06/30/2022 | ANGN | Buy Now | Angion Biomedica | — | — | $50 → $15 | Downgrade | Buy → Hold | Get Alert |